124 related articles for article (PubMed ID: 26884718)
1. Diabetes Induced Changes in Podocyte Morphology and Gene Expression Evaluated Using GFP Transgenic Podocytes.
Xu J; Zheng S; Kralik PM; Krishnan L; Huang H; Hoying JB; Cai L; Carlson EC; Tan Y; Epstein PN
Int J Biol Sci; 2016; 12(2):210-8. PubMed ID: 26884718
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
3. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
4. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes.
Fu J; Wei C; Lee K; Zhang W; He W; Chuang P; Liu Z; He JC
J Am Soc Nephrol; 2016 Apr; 27(4):1006-14. PubMed ID: 26264855
[TBL] [Abstract][Full Text] [Related]
6. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
7. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
10. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
11. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
13. Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment.
Siu B; Saha J; Smoyer WE; Sullivan KA; Brosius FC
BMC Nephrol; 2006 Mar; 7():6. PubMed ID: 16539708
[TBL] [Abstract][Full Text] [Related]
14. [Study on the effect and mechanism of ascorbic acid on renal podocytes in diabetes].
Qin QJ; Deng HC; Zhao TF; Cao WF; Liu DF; Lan LZ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):112-5. PubMed ID: 21141572
[TBL] [Abstract][Full Text] [Related]
15. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
16. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
Chen LP; Zhou QL; Peng WS; Wu XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
[TBL] [Abstract][Full Text] [Related]
17. Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.
Kwak SJ; Paeng J; Kim DH; Lee SH; Nam BY; Kang HY; Li JJ; Jung DS; Han SH; Ryu DR; Park JT; Chang TI; Yoo TH; Han DS; Kang SW
Apoptosis; 2011 May; 16(5):478-90. PubMed ID: 21373934
[TBL] [Abstract][Full Text] [Related]
18. Podocin-green fluorescence protein allows visualization and functional analysis of podocytes.
He B; Ebarasi L; Hultenby K; Tryggvason K; Betsholtz C
J Am Soc Nephrol; 2011 Jun; 22(6):1019-23. PubMed ID: 21566056
[TBL] [Abstract][Full Text] [Related]
19. Ameliorating effects of L-carnitine on diabetic podocyte injury.
Fan JP; Kim D; Kawachi H; Ha TS; Han GD
J Med Food; 2010 Dec; 13(6):1324-30. PubMed ID: 20946020
[TBL] [Abstract][Full Text] [Related]
20. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
